Prognostic value of lower tract urinary symptoms in clinically regional lymph node-positive prostate cancer

LEANDRO BLAS, KOSUKE IEIRI, MASAKI SHIOTA, SHOHEI NAGAKAWA, SHIGEHIRO TSUKAHARA, Takashi Matsumoto, EIJI KASHIWAGI, ario takeuchi, JUNICHI INOKUCHI, KEN ICHIRO SHIGA, Akira Yokomizo, MASATOSHI ETO

Research output: Contribution to journalArticlepeer-review

Abstract

Background/Aim: To explore the prognostic value of lower urinary tract symptoms (LUTS) in patients with newly diagnosed regional lymph node-positive prostate cancer. Patients and Methods: The prognostic value of LUTS for progression-free (PFS) and overall (OS) survival, as well as the differential prognostic impact of radiotherapy by LUTS was investigated. Results: Univariate Cox-model analysis showed a statistically significantly increased hazard risk for PFS and OS for men with International Prostate Symptom Score (IPSS)≥19 and Overactive Bladder Symptom Score (OABSS) ≥8 at diagnosis. Patients with lower IPSS had a better PFS at 5 years (70.0% vs. 51.9%, p=0.027) and OS at 5 year (89.3% vs. 73.6%, p=0.016). Similarly, a lower OABSS was associated with greater PFS at 5 years (67.4% vs. 23.4%, p<0.001) and OS at 5 years (85.3% vs. 57.1%, p=0.012). Conclusion: IPSS and OABSS were prognostic for PFS and OS in patients with regional lymph node-metastatic prostate cancer.

Original languageEnglish
Pages (from-to)5593-5598
Number of pages6
JournalAnticancer research
Volume41
Issue number11
DOIs
Publication statusPublished - Nov 2021

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Prognostic value of lower tract urinary symptoms in clinically regional lymph node-positive prostate cancer'. Together they form a unique fingerprint.

Cite this